Windtree Therapeutics Inc. (WINT)
Market Closed
15 Oct, 08:00 PM
OTC PINK OTC PINK Primary $
0. 00
0
0%
$
33.71K Market Cap
- P/E Ratio
- Div Yield
70,000 Volume
- Eps
$ 0
Previous Close Want to track WINT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?
Windtree Therapeutics (NASDAQ: WINT ) stock is rocketing higher on Friday after the biotechnology company provided an update on its clinical trial of istaroxime. Windtree Therapeutics notes that it is expecting its Phase 2 Phase 2 SEISMiC Extension Study to complete enrollment within the company weeks.
Investorplace | 2 years ago
2026 © Marketlog. All Rights Reserved.
